SCHEMBL48525

SCHEMBL48525

COc1ccc(CC(C)=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.66
POLB P06746 2/20 0.63
SMN1; SMN2 Q16637 3/20 0.59
CTBP2 P56545 1/20 0.58
PKM P14618 2/20 0.56
LDHA P00338 1/20 0.55
ALDH1A1 P00352 2/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C19 P33261 1/20 0.54
USP2 O75604 1/20 0.54
TP53 P04637 1/20 0.54
KDM4E B2RXH2 1/20 0.54
MAPT P10636 2/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
F2RL1 P55085 1/20 0.53
NPC1 O15118 1/20 0.53
LMNA P02545 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28709451 1.00 HTT (0.66) HTTPOLBSMN1; SMN2CTBP2PKM
SCHEMBL9262585 0.94 HTT (0.59) HTTPOLBSMN1; SMN2CTBP2PKM
SCHEMBL9417745 0.94 HTT (0.59) HTTPOLBSMN1; SMN2CTBP2PKM
SCHEMBL7149097 0.94 HTT (0.59) HTTPOLBSMN1; SMN2CTBP2PKM
SCHEMBL29111694 0.89 POLB (0.57) HTTPOLBSMN1; SMN2CTBP2PKM
SCHEMBL11346487 0.89 HTT (0.54) HTTPOLBSMN1; SMN2CTBP2PKM
Propylene Glycol SCHEMBL29111692 0.89 POLB (0.62) HTTPOLBSMN1; SMN2CTBP2PKM
SCHEMBL18327985 0.88 HTT (0.53) HTTPOLBSMN1; SMN2CTBP2PKM
SCHEMBL12895869 0.86 SMN1; SMN2 (0.57) HTTPOLBSMN1; SMN2PKMALDH1A1
Anisole SCHEMBL29180163 0.86 ALDH1A1 (0.58) HTTSMN1; SMN2ALDH1A1USP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260069551-A1 Patch for treating demyelinating diseases UNIV MAINZ JOHANNES GUTENBERG (DE) 2026-03-12 US claimed
EP-4587027-A1 PATCH FOR TREATING DEMYELINATING DISEASES Johannes Gutenberg-Universität Mainz (DE) 2025-07-23 EP claimed
CN-120117981-A Method for preparing mono-fatty glyceride by cucurbituril acid enrichment 四川大学 2025-06-10 CN claimed
CN-119684105-A N-phenyl isatin-mediated ketone-carboxylic acid conversion reaction method 贵州医科大学 2025-03-25 CN claimed
CN-119431161-A Synthesis method of mebeverine hydrochloride 河北广祥制药有限公司 2025-02-14 CN claimed
US-20250034072-A1 SYNTHESIS METHOD OF NATURE-IDENTICAL RASPBERRY KEYTONE Dai, Huifang (CN) 2025-01-30 US claimed
CN-119118851-A Synthesis method of mebeverine hydrochloride 南京斯泰尔医药科技有限公司 2024-12-13 CN claimed
CN-116217363-B Method for continuously synthesizing 4-methoxy propiophenone 江苏宏邦化工科技有限公司 2024-09-03 CN claimed
CN-118221610-A Phenylthiazole amine PI4KIII beta/HDAC double-target inhibitor, preparation method, pharmaceutical composition and application thereof 南京市鸿舜医药科技有限公司 2024-06-21 CN claimed
CN-117904097-A Self-assembled protein scaffold co-immobilized enzyme and application thereof 浙江工业大学 2024-04-19 CN claimed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US claimed
CN-1674862-A Perfume composition KAO CORP (JP) 2005-09-28 CN claimed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP claimed
CN-1602835-A Aerosol cosmetic composition KAO CORP (JP) 2005-04-06 CN claimed
EP-0938467-B1 PROCESS FOR THE PREPARATION OF OPTICALLY PURE ISOMERS OF FORMOTEROL SEPRACOR INC (US) 2002-06-12 EP claimed
EP-1210966-A1 Gas filter media with donor and/or acceptor function PAPIERFABRIK SCHOELLER & HOESCH GMBH & CO. KG (DE) 2002-06-05 EP claimed
US-6268533-B1 REACTING 4-BENZYLOXY-3-FORMAMIDOSTYRENE OXIDE WITH AN OPTICALLY PURE 4-METHOXY-.ALPHA.-METHYL-N-(PHENYLMETHYL)BENZENEETHANAMINE FOLLOWED BY REDUCTION TO PRODUCE FORMOTEROL SEPRACOR INC. 2001-07-31 US claimed
EP-0938467-A1 PROCESS FOR THE PREPARATION OF OPTICALLY PURE ISOMERS OF FORMOTEROL SEPRACOR, INC. (US) 1999-09-01 EP claimed
US-5944026-A FLAVORED CIGARETTE H.F. & PH.F. REEMTSMA GMBH & CO. (DE) 1999-08-31 US claimed
WO-1998021175-A1 PROCESS FOR THE PREPARATION OF OPTICALLY PURE ISOMERS OF FORMOTEROL SEPRACOR, INC. (US) 1998-05-22 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260069551-A1 Patch for treating demyelinating diseases PMP22, PLP2, MYT1 HTT 460/4885POLB 491/4885SMN1; SMN2 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.